Current Oncology (Mar 2021)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting

  • Michalis Liontos,
  • Alkistis Papatheodoridi,
  • Angeliki Andrikopoulou,
  • Nikolaos Thomakos,
  • Dimitrios Haidopoulos,
  • Alexandros Rodolakis,
  • Flora Zagouri,
  • Aristotelis Bamias,
  • Meletios-Athanasios Dimopoulos

DOI
https://doi.org/10.3390/curroncol28020110
Journal volume & issue
Vol. 28, no. 2
pp. 1143 – 1152

Abstract

Read online

Treatment of elderly patients with neoplasia is challenging. Age is a known prognostic factor in ovarian cancer but the optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced-stage ovarian cancer patients older than 70 years of age. Methods: Medical records of women with high-grade serous ovarian cancer, stage III and IV were retrospectively analyzed. Results: A total of 735 patients were identified with a median age of 61.5 years. 22.4% among them were older than 70 years of age at diagnosis. First-line Progression-Free Survival (PFS) and Overall Survival (OS) were significantly worse in elderly patients in comparison to the younger ones [mPFS 11.3 months vs. 14.8 months, (p p Conclusions: Elderly ovarian cancer patients have a worse prognosis. Comprehensive geriatric assessment should be performed for the optimal treatment of these patients.

Keywords